Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches
Combined Nonpharmacological Therapies for MTBI-Related Headaches
Veterans Medical Research Foundation
240 participants
Jan 1, 2022
INTERVENTIONAL
Conditions
Summary
This study will assess the combined effectiveness of repetitive transcranial magnetic stimulation (rTMS) and telehealth based therapy in helping manage mild traumatic brain injury (mTBI) related headaches. The investigators hypothesize that active rTMS combined with telehealth therapy will provide marked reduction in mTBI related headaches and symptoms in comparison to their placebo counterparts.
Eligibility
Inclusion Criteria6
- Mild Traumatic Brain Injury (mTBI)
- Chronic headaches \> 3 months after injury
- Aged 18-65
- No prior TMS treatment
- Persistent Headaches with an intensity \> 30 / 100
- No history of daily headache prior to mTBI
Exclusion Criteria9
- Pregnant
- Pacemaker or any metal in body that would prevent MRI
- History of dementia or major psychiatric disease, such as bipolar disorder or schizophrenia
- Presence of any other chronic neuropathic pain states
- History of seizure
- Pending litigation
- Can't understand English
- History of chronic headache like migraine prior to mTBI
- Evidence in chart of exacerbation of depressive/anxiety symptoms, active substance dependence, suicidal intent or attempt within previous month
Interventions
In the control, educational sessions on headaches will be provided.
Active rTMS will be given at the left dorsolateral prefrontal cortex with a double blind TMS coil.
Therapy will be provided on headache management.
Sham rTMS will be given at the left dorsolateral prefrontal cortex. All parameters of the treatment will appear identical to the active treatment, with only the rTMS coil used to administer the treatment flipped 180 degrees to prevent stimulation.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05176392